Trial Profile
A Randomized, Double Blind, Double Dummy, Placebo Controlled Phase III Trial to Evaluate the Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia(COCTAIL Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Valsartan (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Acronyms COCTAIL
- Sponsors JW Pharmaceutical
- 12 May 2014 Trial status changed to completed as reported by ClinicalTrials.gov.
- 01 Aug 2011 New trial record